Four Tips For Harnessing Growth In East Africa
This article was originally published in Scrip
Pharmaceutical companies may be tempted by the lure of the East African Community, where the discovery of oil and minerals, a growing middle class and the growing need for innovative medicines means the pharmaceutical market is likely to almost double within the next seven years. William Mwatu, chairman of KAPI (Kenya Association of the Pharmaceutical Industry) tells Scrip what companies need to know about how to successfully grow business there.
You may also be interested in...
The R&D-based lobby group, Medicines Australia, has published a report calling for stakeholders across the Australian healthcare ecosystem to discuss how to “pragmatically address the evidence needs of the future.”
NICE will review new data in deciding whether to ok the use of Spinraza in non-ambulant SMA type III patients.
WTO member states including the EU, the US and the UK argue that waiving certain IP rights is unnecessary for enhancing responses to the Covid-19 pandemic.